These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Longterm clinical remission of oral and cutaneous pemphigus with thalidomide. Lee FC Int J Dermatol; 2011 Sep; 50(9):1120-3. PubMed ID: 22126875 [No Abstract] [Full Text] [Related]
9. New long-lasting lozenge protectant vehicle for oral mucosal disease. Kutscher AH; Zegarelli EV; Ruiz L; Rosell A; Mehrhof A N Y State J Med; 1969 Mar; 69(5):687-9. PubMed ID: 5252482 [No Abstract] [Full Text] [Related]
10. [Treatment of oral mucosal lesions with Solcoseryl-comp. adhesive paste--report after seven years]. Porteder H; Rausch E; Vinzenz K; Kienmayer T; Jaskulka U; Henning G Quintessenz; 1988 Apr; 39(4):635-40. PubMed ID: 3200967 [No Abstract] [Full Text] [Related]
11. Thalidomide, orogenital ulcers, and the risk of teratogenesis. Lehner T; Sullivan FM Lancet; 1985 Feb; 1(8423):288-9. PubMed ID: 2857357 [No Abstract] [Full Text] [Related]
12. Chronic graft versus host disease of oral mucosa: review of available therapies. Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918 [TBL] [Abstract][Full Text] [Related]
13. [Carident in the treatment of oral mucosa diseases]. Jańczuk Z; Banach J; Syryńska M Czas Stomatol; 1987 Jul; 40(7):503-6. PubMed ID: 3506500 [No Abstract] [Full Text] [Related]
14. [Clinical and therapeutic results obtained in the treatment of affections of the buccal mucosa with an adhesive apiphytotherapeutic preparation, "Propovit MSK"]. Mitroi NM; Luchian S; Kozma A; Marin L Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Stomatol; 1987; 34(4):261-4. PubMed ID: 2977846 [No Abstract] [Full Text] [Related]
15. [Metindonium in the treatment of oral mucosa diseases]. Knychalska-Karwan Z; Gawrzewska B; Pasztaleniec D Czas Stomatol; 1987 Oct; 40(10):740-4. PubMed ID: 3506461 [No Abstract] [Full Text] [Related]
16. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis. Yang Y; Ge JP; Zhou ZT J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066 [TBL] [Abstract][Full Text] [Related]
17. [Drugs for use in the mouth cavity]. Kircher W Med Monatsschr Pharm; 1990 Mar; 13(3):84-5. PubMed ID: 2319985 [No Abstract] [Full Text] [Related]
18. [The prevalence of oral mucosal lesions in Hungary]. Jáhn M; Schmidt J; Fejérdy L; Tollas OL; Fejérdy P; Madléna M Fogorv Sz; 2007 Apr; 100(2):59-63. PubMed ID: 17546896 [TBL] [Abstract][Full Text] [Related]
19. Oral and maxillofacial pathology case of the month. Herpes zoster (shingles). Bouquot JE; Horn N; Wan SF Tex Dent J; 2007 Jan; 124(1):132, 136-8. PubMed ID: 17380914 [No Abstract] [Full Text] [Related]
20. Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide. Powell RJ; Allen BR; Jenkins JS; Steele L; Hunneyball I; Maurice PD; Littlewood SM Br J Dermatol; 1985 Jul; 113 Suppl 28():141-4. PubMed ID: 4040386 [No Abstract] [Full Text] [Related] [Next] [New Search]